Cryptosporidium parvum, a potential cause of colic adenocarcinoma

Infectious Agents and Cancer

Volumn 2, Issue 1, 2007, Pages

  Certad, Gabriela ^a,b   Ngouanesavanh, Tramy ^a   Guyot, Karine ^a   Gantois, Nausicaa ^a   Chassat, Thierry ^c   Mouray, Anthony ^c   Fleurisse, Laurence ^d   Pinon, Anthony ^c   Cailliez, Jean Charles ^d   Dei Cas, Eduardo ^a   Creusy, Colette ^d  

^a UNIV LILLE   (France)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c INSTITUT PASTEUR DE LILLE   (France)

^d UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM MURIS; CRYPTOSPORIDIUM PARVUM; DRUG EFFECT; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; INTESTINE CANCER; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; RECTUM POLYP; SCID MOUSE;

EID: 38849141802     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-2-22     Document Type: Article

References (47)

1. Advances in the epidemiology, diagnosis and treatment of cryptosporidiosis. SM Caccio E Pozio, Expert Rev Anti Infect Ther 2006 4 429 443 10.1586/14787210.4.3.429 16771620
2. Cryptosporidium taxonomy: recent advances and implications for public health. L Xiao R Fayer U Ryan SJ Upton, Clin Microbiol Rev 2004 17 72 97 14726456 10.1128/CMR.17.1.72-97.2004
3. The impact of HIV-protease inhibitors on opportunistic parasites. E Pozio MA Morales, Trends Parasitol 2005 21 58 63 10.1016/j.pt.2004.11.003 15664527
4. Cryptosporidium. O Sunnotel CJ Lowery JE Moore JS Dooley L Xiao BC Millar PJ Rooney WJ Snelling, Lett Appl Microbiol 2006 43 7 16 10.1111/j.1472-765X. 2006.01936.x 16834714
5. Intestinal and extraintestinal cryptosporidiosis in AIDS patients. R Lopez-Velez R Tarazona A Garcia Camacho E Gomez-Mampaso A Guerrero V Moreira R Villanueva, Eur J Clin Microbiol Infect Dis 1995 14 677 681 10.1007/BF01690873 8565984
6. Cryptosporidium parvum activates nuclear factor kappaB in biliary epithelia preventing epithelial cell apoptosis. XM Chen SA Levine PL Splinter PS Tietz AL Ganong C Jobin GJ Gores CV Paya NF LaRusso, Gastroenterology 2001 120 1774 1783 10.1053/gast.2001.24850 11375958
7. Cryptosporidium parvum at different developmental stages modulates host cell apoptosis in vitro. R Mele MA Gomez Morales F Tosini E Pozio, Infect Immun 2004 72 6061 6067 15385510 10.1128/IAI.72.10.6061-6067.2004
8. Population structures and the role of genetic exchange in the zoonotic pathogen Cryptosporidium parvum. M Mallon A MacLeod J Wastling H Smith B Reilly A Tait, J Mol Evol 2003 56 407 417 10.1007/s00239-002-2412-3 12664161
9. Microsatellite analysis of Cryptosporidium hominis and C. parvum in Portugal: a preliminary study. M Alves O Matos F Antunes, J Eukaryot Microbiol 2003 50 Suppl 529 530 10.1111/j.1550-7408.2003.tb00619.x 14736152
10. Emergence of distinct genotypes of Cryptosporidium parvum in structured host populations. S Tanriverdi A Markovics MO Arslan A Itik V Shkap G Widmer, Appl Environ Microbiol 2006 72 2507 2513 16597950 10.1128/AEM.72.4.2507-2513. 2006
11. Cryptosporidium Population Genetics: Evidence of Clonality in Isolates from France and Haiti. T Ngouanesavanh K Guyot G Certad YL Fichoux C Chartier RI Verdier JC Cailliez D Camus E Dei-Cas AL Banuls, J Eukaryot Microbiol 2006 53 Suppl:S33 S36 10.1111/j.1550-7408.2006.00166.x
12. Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice. V McDonald R Deer S Uni M Iseki GJ Bancroft, Infect Immun 1992 60 3325 3331 1639500
13. Persistent Cryptosporidium infection in congenitally athymic (nude) mice. J Heine HW Moon DB Woodmansee, Infect Immun 1984 43 856 859 6607888
14. Infectivity of Cryptosporidium muris (strain RN 66) in various laboratory animals. M Iseki T Maekawa K Moriya S Uni S Takada, Parasitol Res 1989 75 218 222 10.1007/BF00931279 2523540
15. Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. JR Mead MJ Arrowood RW Sidwell MC Healey, J Infect Dis 1991 163 1297 1304 2037795
16. Murine infection model for maintenance and amplification of Cryptosporidium parvum oocysts. F Petry HA Robinson V McDonald, J Clin Microbiol 1995 33 1922 1924 7665672
17. Infectivity of a Cryptosporidium parvum isolate of cervine origin for healthy adults and interferon-g knockout mice. PC Okhuysen SM Rich CL Chappell KA Grimes G Widmer X Feng S Tzipori, J Infect Dis 2002 185 1320 1325 10.1086/340132 12001050
18. Kinetics of Cryptosporidium parvum-specific cytokine responses in healing and nonhealing murine models of C. parvum infection. I Singh C Theodos W Li S Tzipori, Parasitol Res 2005 97 309 317 10.1007/s00436-005-1436-1 16052360
19. Recent advances in cryptosporidiosis: the immune response. MW Riggs, Microbes Infect 2002 4 1067 1080 10.1016/S1286-4579(02)01631-3 12191657
20. SCID mice and the study of parasitic disease. KB Seydel SL Stanley Jr., Clin Microbiol Rev 1996 9 126 134 8964031
21. Expression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection. P Robinson PC Okhuysen CL Chappell DE Lewis I Shahab S Lahoti AC White Jr., Cytokine 2001 15 39 46 10.1006/cyto.2001.0888 11509007
22. Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum. RC Pollok MJ Farthing M Bajaj-Elliott IR Sanderson V McDonald, Gastroenterology 2001 120 99 107 10.1053/gast.2001.20907 11208718
23. Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies. D Franchimont, Ann N Y Acad Sci 2004 1024 124 137 10.1196/annals.1321.009 15265777
24. Novel genomic effects of glucocorticoids in epidermal keratinocytes: inhibition of apoptosis, interferon-gamma pathway, and wound healing along with promotion of terminal differentiation. O Stojadinovic B Lee C Vouthounis S Vukelic I Pastar M Blumenberg H Brem M Tomic-Canic, J Biol Chem 2007 282 4021 4034 10.1074/jbc.M606262200 17095510
25. Immunocompetent hosts as a reservoir of Pneumocystis organisms: histological and rt-PCR data demonstrate active replication. M Chabé E Dei-Cas C Creusy L Fleurisse N Respaldiza D Camus I Durand-Joly, Eur J Clin Microbiol Infect Dis 2004 23 89 97 10.1007/s10096-003-1092-2 14712369
26. Chemically and genetically immunocompromised mice are not more susceptible than immunocompetent mice to infection with Cryptosporidium muris. TA Miller MW Ware LJ Wymer FW Schaefer 3rd, Vet Parasitol 2007 143 99 105 10.1016/j.vetpar.2006.08.012 16962704
27. The pathogenesis of experimental infections of Cryptosporidium muris (strain RN 66) in outbred nude mice. MA Taylor RN Marshall JA Green J Catchpole, Vet Parasitol 1999 86 41 48 10.1016/S0304-4017(99)00114-4 10489201
28. Characterization of a Cryptosporidium muris infection and reinfection in CF-1 mice. TA Miller FW Schaefer 3rd, Vet Parasitol 2007 144 208 221 10.1016/j.vetpar.2006.10.026 17197093
29. Anatomy and physiology of the stomach. DI Soybel, Surg Clin North Am 2005 85 875 94, v 10.1016/j.suc.2005.05.009 16139026
30. Pathogenicity of Cryptosporidium parvum - evaluation of an animal infection model. HL Enemark V Bille-Hansen P Lind PM Heegaard H Vigre P Ahrens SM Thamsborg, Vet Parasitol 2003 113 35 57 10.1016/S0304-4017(03)00034-7 12651216
31. Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin. S Tzipori W Rand J Griffiths G Widmer J Crabb, Clin Diagn Lab Immunol 1994 1 450 463 8556484
32. Aural-pharyngeal polyps associated with Cryptosporidium infection in three iguanas (Iguana iguana). EW Uhl E Jacobson TE Bartick J Micinilio R Schimdt, Vet Pathol 2001 38 239 242 10.1354/vp.38-2-239 11280385
33. Infection dynamics and clinical features of cryptosporidiosis in SCID mice. JR Mead N Ilksoy X You Y Belenkaya MJ Arrowood MT Fallon RF Schinazi, Infect Immun 1994 62 1691 1695 8168930
34. Cryptosporidium virulence determinants - are we there yet? PC Okhuysen CL Chappell, Int J Parasitol 2002 32 517 525 10.1016/S0020-7519(01)00356-3 11943224
35. The Severe Combined Immunodeficiency (scid) Mutation. JP Sundberg LD Shultz, JAX NOTES 1993 453
36. Cryptosporidiosis of the biliary tract mimicking pancreatic cancer in an AIDS patient. R de Souza Ldo MA Rodrigues J Morceli R Kemp RP Mendes, Rev Soc Bras Med Trop 2004 37 182 185 15094908
37. Cryptosporidiosis in patients with colorectal cancer. V Sulzyc-Bielicka W Kuzna-Grygiel L Kolodziejczyk D Bielicki J Kladny M Stepien-Korzonek B Telatynska-Smieszek, J Parasitol 2007 93 722 724 10.1645/GE-1025R1.1 17626376
38. The global health burden of infection-associated cancers in the year 2002. DM Parkin, Int J Cancer 2006 118 3030 3044 10.1002/ijc.21731 16404738
39. Association of parasitic infections and cancers. S Khurana ML Dubey N Malla, Indian J Med Microbiol 2005 23 74 79 15928434
40. Inflammation, atrophy, and gastric cancer. JG Fox TC Wang, J Clin Invest 2007 117 60 69 17200707 10.1172/JCI30111
41. Colorectal malignancies in HIV-positive patients. JF Yeguez SA Martinez DR Sands LR Sands MD Hellinger, Am Surg 2003 69 981 987 14627261
42. Mouse models for colorectal cancer. J Heyer K Yang M Lipkin W Edelmann R Kucherlapati, Oncogene 1999 18 5325 5333 10.1038/sj.onc.1203036 10498885
43. Mouse models of gastrointestinal tumors. MM Taketo, Cancer Sci 2006 97 355 361 10.1111/j.1349-7006.2006.00190.x 16630131
44. Influence Of US Epa 1622 Method Successive Steps On The Viability Of Cryptosporidium Oocysts. K Guyot MF Gireaudot-Liepmann A Cabon I Riveau-Ricard M Lange JM Delattre E Dei-Cas, Water Science & Technology 2000 41 189 196
45. Staining of cryptosporidia by a modified Ziehl-Neelsen technique. SA Henriksen JF Pohlenz, Acta Vet Scand 1981 22 594 596 6178277
46. Pathology and Genetics.Tumours of the Digestive System. WHO classification of tumours. SR Hamilton LA Aalfonen eds., Lyon, IARC Press 2000 111 10763380
47. The new Vienna classification of epithelial neoplasia of the gastrointestinal tract: advantages and disadvantages. M Stolte, Virchows Arch 2003 442 99 106 12596058